In: Nursing
1-What is the difference between T lymphocyte cell and the Natural Killer cell? 2-Please write how humoral immunity and cellular immunity combat microorganisms? What is the difference of this action? 3-What is a Cytokine Storm? 4-What are CD8 cells? 5-What is the general prognosis for Infectious Mononucleosis? 6-What does TORCH stand for? 7-What is a Prion infection? 8-Why still are not vaccines against Hepatitis C virus? 9-Which markers specifically define Chronic Hepatitis B? 10-Why Diphteria infectious disease is increasing its frequency in USA? 11-How is feasible to break down the Dengue virus chain of infection? 12-What are you currently doing not to be contaminated with the Coronavirus agent?
1. NK cells were first noticed for their ability to kill tumour cells without any priming or prior activation (in contrast to cytotoxic T cells, which need priming by antigen presenting cells). ... Cancer cells and infected cells often lose their MHC I, leaving them vulnerable to NK cell killing.
Natural killer (NK) cells and natural killer T (NKT) cells are two types of important cells in innate immunity. ... The main difference between NK cells and NKT cells is that NK cells are large granular lymphocytes while NKT cells are a type of T cells.
2. The extracellular spaces are protected by the humoral immune response, in which antibodies produced by B cells cause the destruction of extracellular microorganisms and prevent the spread of intracellular infections. The activation of B cells and their differentiation into antibody-secreting plasma cells
Humoral immunity secretes antibodies to fight against antigens, whereas cell-mediated immunity secretes cytokines and no antibodies to attack the pathogens. The Humoral immunity is rapid or quick in their action against antigens, while the Cell-mediated immunity show delay though permanent action against any pathogens.
3. A severe immune reaction in which the body releases too many cytokines into the blood too quickly. Cytokines play an important role in normal immune responses, but having a large amount of them released in the body all at once can be harmful. A cytokine storm can occur as a result of an infection, autoimmune condition, or other disease. It may also occur after treatment with some types of immunotherapy. Signs and symptoms include high fever, inflammation (redness and swelling), and severe fatigue and nausea. Sometimes, a cytokine storm may be severe or life threatening and lead to multiple organ failure. Also called hypercytokinemia.
4. CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous or virally infected cells, and CD8-positive suppressor T cells, which restrain certain types of immune response
CD8+ (cytotoxic) T cells, like CD4+ Helper T cells, are generated in the thymus and express the T-cell receptor. ... CD8+ T cells (often called cytotoxic T lymphocytes, or CTLs) are very important for immune defence against intracellular pathogens, including viruses and bacteria, and for tumour surveillance.
5. Most people with mono recover completely with no long-term problems. The fatigue associated with the condition may persist for a few months after the fever and other symptoms have resolved. Severe complications as described above are very rare.
6. The full form of TORCH is toxoplasmosis, rubella cytomegalovirus, herpes simplex, and HIV. However, it can also contain other newborn infections. Sometimes the test is spelled TORCHS, where the extra "S" stands for syphilis.
7. Prions are misfolded proteins with the ability to transmit their misfolded shape onto normal variants of the same protein. They characterize several fatal and transmissible neurodegenerative diseases in humans and many other animals.
8. Among the difficulties that have hampered the development of a vaccine against HCV there are its extreme genetic variability, the lack of small animal models for testing vaccines, and the fact that a cell culture system supporting the production of infectious HCV and allowing studies on virus neutralization in vitro .
With an estimated 3% of the world’s population chronically infected, hepatitis C virus (HCV) represents a major health problem for which an efficient vaccination strategy would be highly desirable. Indeed, chronic hepatitis C is recognized as one of the major causes of cirrhosis, hepatocarcinoma and liver failure worldwide and it is the most common indication for liver transplantation, accounting for 40–50% of liver transplants. Much progress has been made in the prevention of HCV transmission and in therapeutic intervention. However, even if a new wave of directly acting antivirals promise to overcome the problems of low efficacy and adverse effects observed for the current standard of care, which include interferon-a and ribavirin, an effective vaccine would be the only means to definitively eradicate infection and to diminish the burden of HCV-related diseases at affordable costs. Although there is strong evidence that the goal of a prophylactic vaccine could be achieved, there are huge development issues that have impeded reaching this goal and that still have to be addressed. In this article we address the question of whether an HCV vaccine is needed, whether it will eventually be feasible, and why it is so difficult to produce.
9. Hepatitis B surface antigen (HBsAg) is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B, and persistence of HBsAg for more than 6 months suggests chronic HBV infection.
Anti‐HBc IgM (hepatitis B core antibody) is observed during
acute infection.
Anti‐HBc (total antibody against HBV core antigen) indicates the
presence of IgM
and/or IgG against the core antigen. A positive total anti‐HBc with
negative anti‐
HBc IgM antibodies indicates resolved infection.
HBeAg (hepatitis B envelope antigen) is viral protein associated
usually with a
high viral load and high infectivity.
Anti‐HBe (antibody to HBeAg) usually indicates decreasing HBV
DNA.
Anti‐HBs is a neutralizing antibody..
11.
Healthcare exists in an ever-changing world, so there is a continuing need for medical professionals to be able to identify and address new and existing health issues. For example, it’s important to remember the links related to an infection in order to help prevent the spread of it.
The term “chain of infection” refers to the conditions (links) that must be met in order for an infectious disease to spread. The idea of breaking the chain of infection means stopping at least one of those links, thus preventing it from starting again. If unchecked, certain infections can spread rapidly through the chain.
Listed below are the six links in the chain of infection, as well as ways to break that chain.
Here are ways to help reduce the spread of airborne infections:
12.
Know how it spreads
Less common ways COVID-19 can spread
Everyone Should
Wash your hands often
Avoid close contact
Cover your mouth and nose with a mask when around others
Cover coughs and sneezes
Clean and disinfect
Monitor Your Health Daily